Literature DB >> 24734155

Colorectal carcinoma in a Southern Mediterranean country: The Libyan scenario.

Zuhir Bodalal1, Riyad Bendardaf1.   

Abstract

AIM: To study the salient features of colorectal cancer (CRC) in Libya.
METHODS: Patients records were gathered at the primary oncology clinic in eastern Libya for the period of one calendar year (2012). Using this data, various parameters were analyzed and age-standardized incidence rates were determined using the direct method and the standard population.
RESULTS: During 2012, 174 patients were diagnosed with CRC, 51.7% (n = 90) male and 48.3% (n = 84) females. The average age was 58.7 (± 13.4) years, with men around 57.3 (± 13) years old and women usually 60.1 (± 13.8) years of age. Libya has the highest rate of CRC in North Africa, with an incidence closer to the European figures. The age-standardized rate for CRC was 17.5 and 17.2/100000 for males and females respectively. It was the second most common cancer, forming 19% of malignancies, with fluctuation in ranking and incidence in different cities/villages. Increasingly, younger ages are being afflicted and a higher proportion of patients are among the > 40 years subset. Nearly two-thirds presented at either stage III (22.4%) or IV (38.4%).
CONCLUSION: Cancer surveillance systems should be established in order to effectively monitor the situation. Likewise, screening programs are invaluable in the Libyan scenario given the predominance of sporadic cases.

Entities:  

Keywords:  Age-standardized rates; Benghazi, Libya; Cancer incidence; Colorectal carcinoma; North Africa; Urban-rural differences; Young age

Year:  2014        PMID: 24734155      PMCID: PMC3981974          DOI: 10.4251/wjgo.v6.i4.98

Source DB:  PubMed          Journal:  World J Gastrointest Oncol


  18 in total

Review 1.  Biology and genetics of colorectal cancer.

Authors:  J Walker; P Quirke
Journal:  Eur J Cancer       Date:  2001-10       Impact factor: 9.162

2.  Urban-rural differences in breast cancer incidence in Egypt (1999-2006).

Authors:  Subhojit Dey; Amr S Soliman; Ahmad Hablas; Ibrahim A Seifeldein; Kadry Ismail; Mohamed Ramadan; Hesham El-Hamzawy; Mark L Wilson; Mousumi Banerjee; Paolo Boffetta; Joe Harford; Sofia D Merajver
Journal:  Breast       Date:  2010-05-08       Impact factor: 4.380

Review 3.  Chemotherapy in metastatic colorectal cancer.

Authors:  A Christopoulou
Journal:  Tech Coloproctol       Date:  2004-11       Impact factor: 3.781

4.  Incidence and age distribution of colorectal cancer in Iran: results of a population-based cancer registry.

Authors:  Reza Ansari; Mahboobeh Mahdavinia; Alireza Sadjadi; Mehdi Nouraie; Farin Kamangar; Faraz Bishehsari; Hafez Fakheri; Shahriar Semnani; Shahnam Arshi; Mohammad-Javad Zahedi; Sodeif Darvish-Moghadam; Fariborz Mansour-Ghanaei; Alireza Mosavi; Reza Malekzadeh
Journal:  Cancer Lett       Date:  2005-11-08       Impact factor: 8.679

Review 5.  Geriatric oncology: a clinical approach to the older patient with cancer.

Authors:  L Repetto; A Venturino; L Fratino; D Serraino; G Troisi; W Gianni; M Pietropaolo
Journal:  Eur J Cancer       Date:  2003-05       Impact factor: 9.162

Review 6.  Cancer epidemiology in the elderly.

Authors:  S Franceschi; C La Vecchia
Journal:  Crit Rev Oncol Hematol       Date:  2001-09       Impact factor: 6.312

7.  Proportionate increase in incidence of colorectal cancer at an age below 40 years: an observation.

Authors:  Madhumay Pal
Journal:  J Cancer Res Ther       Date:  2006 Jul-Sep       Impact factor: 1.805

8.  Age distribution, polyps and rectal cancer in the Egyptian population-based cancer registry.

Authors:  Darlene Veruttipong; Amr S Soliman; Samuel F Gilbert; Taylor S Blachley; Ahmed Hablas; Mohamed Ramadan; Laura S Rozek; Ibrahim A Seifeldin
Journal:  World J Gastroenterol       Date:  2012-08-14       Impact factor: 5.742

9.  Cancers in Eastern Libya: first results from Benghazi Medical Center.

Authors:  Zuhir Bodalal; Raouf Azzuz; Riyad Bendardaf
Journal:  World J Gastroenterol       Date:  2014-05-28       Impact factor: 5.742

10.  Cancer epidemiology and control in the arab world - past, present and future.

Authors:  Elsayed I Salim; Malcolm A Moore; Jawad A Al-Lawati; Jamal Al-Sayyad; Amin Bazawir; Abdulbari Bener; Marilys Corbex; Nagi El-Saghir; Omran S Habib; Wasim Maziak; Hamdi Cherif Mokhtar; Ibrahim Abdel-Barr Seif-Eldrin; Tomotaka Sobue
Journal:  Asian Pac J Cancer Prev       Date:  2009 Jan-Mar
View more
  6 in total

1.  Evaluation of the Role of ALDH1 as Cancer Stem Cell Marker in Colorectal Carcinoma: An Immunohistochemical Study.

Authors:  Nanis Shawky Holah; Hayam Abd-El-Samie Aiad; Nancy Yousif Asaad; Enas Abobakr Elkhouly; Ayat Gamal Lasheen
Journal:  J Clin Diagn Res       Date:  2017-01-01

2.  Colorectal carcinoma then and now: What we are learning by comparing two Libyan cancer studies.

Authors:  Zuhir Bodalal
Journal:  Avicenna J Med       Date:  2015 Apr-Jun

3.  Risk Estimation for Lung Cancer in Libya: Analysis Based on Standardized Morbidity Ratio, Poisson-Gamma Model, BYM Model and Mixture Model

Authors:  Maryam Ahmed Alhdiri; Nor Azah Samat; Zulkifley Mohamed
Journal:  Asian Pac J Cancer Prev       Date:  2017-03-01

4.  Formononetin inhibits colon carcinoma cell growth and invasion by microRNA‑149‑mediated EphB3 downregulation and inhibition of PI3K/AKT and STAT3 signaling pathways.

Authors:  Ai-Lei Wang; Yong Li; Qun Zhao; Li-Qiao Fan
Journal:  Mol Med Rep       Date:  2018-04-05       Impact factor: 2.952

5.  Clinicopathological spectrum of colorectal cancer among the population of the KwaZulu-Natal Province in South Africa.

Authors:  Thandinkosi Madiba; Yoshan Moodley; Benn Sartorius; Kurt Sartorius; Colleen Aldous; Maseelan Naidoo; Vishendran Govindasamy; Shona Bhadree; Laura Stopforth; Yuming Ning; Pokala Ravi Kiran
Journal:  Pan Afr Med J       Date:  2020-09-18

6.  HER2 overexpression is a putative diagnostic and prognostic biomarker for late-stage colorectal cancer in North African patients.

Authors:  Eman A Abdul Razzaq; Thenmozhi Venkatachalam; Khuloud Bajbouj; Mohamed Rahmani; Amena Mahdami; Surendra Rawat; Naziha Mansuri; Hussein Alhashemi; Rifat Akram Hamoudi; Riyad Bendardaf
Journal:  Libyan J Med       Date:  2021-12       Impact factor: 1.743

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.